Schedule of calculation of earnings (loss) per share |
The following represents the calculation of earnings (loss) per share (in thousands, except per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
|
|
|
2014 |
|
2013 |
|
2014 |
|
2013 |
|
|
|
(In thousands, except per share amounts)
|
|
Basic: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to common stockholders |
|
$ |
186,853 |
|
$ |
(859,897 |
) |
$ |
35,597 |
|
$ |
(818,060 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average basic number of common shares outstanding |
|
|
416,470 |
|
|
392,726 |
|
|
415,264 |
|
|
368,696 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net income (loss) per share of common stock |
|
$ |
0.45 |
|
$ |
(2.19 |
) |
$ |
0.09 |
|
$ |
(2.22 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to common stockholders |
|
$ |
186,853 |
|
$ |
(859,897 |
) |
$ |
35,597 |
|
$ |
(818,060 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income from assumed conversions |
|
|
9,004 |
|
|
— |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to common stockholders after assumed conversions |
|
$ |
195,857 |
|
$ |
(859,897 |
) |
$ |
35,597 |
|
$ |
(818,060 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average basic number of common shares outstanding |
|
|
416,470 |
|
|
392,726 |
|
|
415,264 |
|
|
368,696 |
|
Common stock equivalent shares representing shares issuable upon: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of stock options |
|
|
741 |
|
|
Anti-dilutive |
|
|
452 |
|
|
Anti-dilutive |
|
Exercise of February 2012 Warrants |
|
|
7,549 |
|
|
Anti-dilutive |
|
|
5,226 |
|
|
Anti-dilutive |
|
Exercise of August 2012 Warrants |
|
|
— |
|
|
— |
|
|
— |
|
|
Anti-dilutive |
|
Vesting of restricted shares |
|
|
2,609 |
|
|
Anti-dilutive |
|
|
1,608 |
|
|
Anti-dilutive |
|
Vesting of performance units |
|
|
463 |
|
|
— |
|
|
483 |
|
|
— |
|
Conversion of 2017 Notes |
|
|
64,371 |
|
|
Anti-dilutive |
|
|
Anti-dilutive |
|
|
Anti-dilutive |
|
Conversion of preferred stock |
|
|
— |
|
|
— |
|
|
— |
|
|
Anti-dilutive |
|
Conversion of Series A preferred stock |
|
|
56,043 |
|
|
Anti-dilutive |
|
|
Anti-dilutive |
|
|
Anti-dilutive |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average diluted number of common shares outstanding |
|
|
548,246 |
|
|
392,726 |
|
|
423,033 |
|
|
368,696 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net income (loss) per share of common stock |
|
$ |
0.36 |
|
$ |
(2.19 |
) |
$ |
0.08 |
|
$ |
(2.22 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|